Pot Stocks are powering ahead, with most up around +40% on the ASX. This rally comes after last week’s Jazz Pharmaceuticals PLC $7 billion deal for the first company to win U.S. regulatory approval for a cannabis-based drug: GW Pharmaceuticals Ltd. GWPH, developer of Epidiolex.
Here is the report of the Top ASX cannabis companies, or Pot Stocks, both over the last month and their performance over the last year.
Little Green Pharma ASX:LGP
Neurotech Intl ASX:NTI
Cann Global Limited ASX:CGB
Mgc Pharmaceuticals ASX:MXC
Stemcell United Ltd ASX:SCU
ECS Botanics Holding ASX:ECS
Shares in Play looks at the leading themes on the ASX and top performing companies within the group over the last month.
#Top6 #PotStocks #FinerMarketPoints #ASX #StencellUnited #MGCPharmaceuticals #CannGlobal #NeurotechInternational #LittleGreenPharma #BestPotStocks